A Meta Analysis of Distal Transradial Access vs. Conventional Transradial

Transradial access is currently the preferred access for diagnostic and therapeutic interventions. However, about 7% of patients experience radial artery occlusion (RAO), which is not expressed by clinical symptoms. However, RAO is a limit for future interventions; it reduces the potential use of that artery as a conduit for aorto-coronary bypass and for the creation of arterio-venous fistula for hemodialysis.

Función de la mano luego del acceso radial distal, ¿es seguro?

This is why distal transradial access has been introduced as an alternative for diagnostic and therapeutic procedures. Randomized studies have shown a lower rate of RAO with distal access.

The aim of this meta-analysis was to evaluate the effects of distal vs. conventional transradial access in angiographic and interventional procedures.

The primary endpoint (PEP) was RAO presence at follow-up. The secondary endpoint (SEP) was the presence of in-hospital RAO, in addition to local hematoma, radial spasm, time to successful radial artery puncture, number of radial puncture attempts, time to introducer insertion, amount of contrast administered, fluoroscopy time, and change in access.

There were 6208 patients included, from 14 randomized studies. Regarding the PEP, the use of distal transradial access was associated with a lower risk of RAO at follow-up up to 60 days (risk ratio [RR]: 0.36; 95% confidence interval [CI]: 0.23- 0.56; p < 0.001; number needed to treat [NNT] = 30), lower rate of in-hospital RAO (RR: 0.32; 95% CI: 0.19- 0.53; p < 0.001; NNT = 28), and lower rate of hematoma EASY ≥2 (RR: 0.51; 95% CI: 0.27 to 0.96; p = 0.04; NNT = 107).

Read also: Hand Function after Distal Radial Access: Is it Safe?

 Regarding the SEP, there were no differences in the rate of local hematoma, radial spasm, or hemostasis time. However, the use of distal transradial access was associated with longer radial artery puncture time (p < 0.001), longer introducer insertion time (p < 0.01), higher number of puncture attempts (p < 0.001), and higher rate of access change (p < 0.001).

Conclusion

This meta-analysis of randomized studies comparing distal vs. conventional transradial access among patients undergoing an angiographic study and/or therapeutic intervention showed that distal transradial access was associated with a lower risk of RAO and hematoma. However, it required more time for puncture and insertion of the introducer and more attempted punctures, and it resulted in high rates of access change.

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention A Meta-Analysis of Randomized Trials.

Reference: Giuseppe Ferrante, MD, PHD et al J Am Coll Cardiol Intv 2022;15:2297–2311.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...